IRT: A competitive advantage to accelerate clinical trials
This insightful article not only looks at the history and advancement of Interactive Response Technology (IRT), but how the newly launched SimplifyTM IRT solution is giving sponsors the competitive edge they need to develop new therapies as quickly as possible and at a lower cost – proving advantageous in the race to end COVID-19 and treatments in a multitude of therapeutic areas.
Download this article and you will learn:
- What to evaluate when moving from trial concept to startup
- Factors that threaten to expand clinical timelines
- Why SimplifyTM is the right IRT to help reduce the time it takes to initiate a clinical trial and get therapies to patients faster than ever before